New Pharmaceutical Regulations In 2008
This article was originally published in PharmAsia News
Executive Summary
New Pharmaceutical Regulations In 2008 Whether China's pharmaceutical industry will continue making gains depends on 2008's health reform plan and new regulations taking effect Jan. 1, such as those for drug GMP authentication standards and pollutant standards. Also coming into effect in the new year are laws for anti-monopoly and new corporate income taxes. Analysts see the revised taxation law, which standardizes tax rates at 25 percent for domestic and foreign-funded companies, as a significant milestone for local enterprises as they will be more competitive with multinational corporations. (Click here for more)